Integris Bass Baptist Health Center
Integris Bass Baptist Health Center was paid $6.42M by Medicaid between Jan 2018 and Nov 2024, across 60 billing codes. Its largest line is 99283, emergency room visit (moderate) — 56% of everything it billed.
ENID, OK 73701
Next to other General Acute Care Hospital providers in Oklahoma
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,599 | $511K | |
| 2019 | 6,010 | $601K | |
| 2020 | 5,253 | $562K | |
| 2021 | 9,885 | $997K | |
| 2022 | 16,984 | $1.53M | |
| 2023 | 17,626 | $1.61M | |
| 2024incomplete | 5,717 | $606K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 56% | 22,005 | 21,682 | $3.59M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 4,659 | 4,613 | $1.13M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 2,175 | 2,136 | $727K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.0% | 2,495 | 2,446 | $322K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.7% | 1,323 | 1,322 | $112K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.4% | 1,047 | 1,033 | $90K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,949 | 7,552 | $63K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 337 | 337 | $44K |
| 80053 | Comprehensive metabolic panel | <1% | 4,069 | 3,912 | $37K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,456 | 5,133 | $35K |
| 95813 | <1% | 133 | 133 | $30K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 345 | 343 | $26K |
48 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 616 | $24K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 496 | $22K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 147 | $20K |
| 87400 | <1% | 825 | $20K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,066 | $14K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 25 | $13K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 252 | $12K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 55 | $9K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,283 | $7K |
| 81001 | <1% | 2,442 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,167 | $6K |
| 81025 | <1% | 840 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 97 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 353 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 100 | $5K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 465 | $5K |
| 84484 | <1% | 369 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 28 | $4K |
| 85027 | <1% | 662 | $4K | |
| 81003 | <1% | 1,794 | $3K | |
| 83690 | <1% | 410 | $2K | |
| 71250 | <1% | 53 | $2K | |
| 87420 | <1% | 156 | $2K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 18 | $2K |
| 87430 | <1% | 115 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 12 | $2K |
| 94060 | <1% | 86 | $2K | |
| 76801 | <1% | 14 | $768.69 | |
| 83605 | <1% | 76 | $751.17 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 105 | $745.97 |
| 87070 | <1% | 85 | $621.62 | |
| 88304 | <1% | 25 | $551.40 | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 12 | $549.50 |
| 82550 | <1% | 97 | $544.26 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 40 | $520.52 |
| 74018 | <1% | 15 | $273.60 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 61 | $271.44 |
| 85610 | <1% | 57 | $213.92 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 12 | $86.09 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 55 | $40.58 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 33 | $13.72 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 119 | $5.92 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 175 | $1.39 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 27 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 88 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 27 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 13 | $0.00 |
| 99152 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Integris Miami Hospital | Miami, OK | $7.24M |
| Integris Canadian Valley Hospital | Yukon, OK | $7.12M |
| Integris Grove Hospital | Grove, OK | $5.80M |
| Integris Health Ponca City Hospital INC | Ponca City, OK | $818K |
| Integris Grove Hospital | Grove, OK | $444K |
| Integris Bass Baptist Health Center | Medford, OK | $376K |
| Integris Bass Baptist Health Center | Waynoka, OK | $303K |
| Integris Health Ponca City Hospital INC | Ponca City, OK | $79K |
| Integris Health Woodward Hospital INC | Woodward, OK | $71K |
| Integris Health Woodward Hospital INC | Woodward, OK | $68K |
| Integris Health Woodward Hospital INC | Woodward, OK | $32K |
| Integris Health Woodward Hospital INC | Woodward, OK | $19K |
| Integris Health Woodward Hospital INC | Mooreland, OK | $6K |
| Integris Health Woodward Hospital INC | Woodward, OK | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.